Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion


Pfizer is in superior talks to purchase World Blood Therapeutics the maker of a lately accepted drug for sickle-cell illness, for about $5 billion, within the newest transfer by the drug large to bolster its portfolio and pipeline.

Pfizer is aiming to seal a deal for GBT within the coming days, in line with folks acquainted with the matter. The scenario remains to be fluid, and different suitors are nonetheless within the combine, a few of the folks stated. GBT broadcasts its second-quarter outcomes Monday.


Please enter your comment!
Please enter your name here

Share post:




More like this

Amazon to Cut 9,000 More Jobs After Earlier Layoffs

CEO Andy Jassy cited an ‘uncertain economy’ and...

Hacks To Improve Sports streaming Experience On HBO Max in Canada

Canadians are extremely sports activities fans and have...

This Makes Me So Happy!

Fixed comes twice every week, really! FRESHER that...